"We know it is safe from the raising of dosing from 3 days to 5 after 30% of patients had gone thru active phase of trial" Close, no cigar. "Upon reaching 25 percent enrollment (30 subjects)" http://www.ipharminc.com/press-release/2021/4/5/innovation-pharma-completes-interim-safety-data-reviewdmc-approves-increased-dosing-frequency-in-phase-2-clinical-trial-of-brilacidin-in-hospitalized-covid-19-patients